Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Birgitte Aga

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
RMD Open|January 12, 2024
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activityKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
Rheumatology (Oxford, England)|July 28, 2018
Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocolNina Paulshus Sundlisæter, Inge C Olsen, Anna-Birgitte Aga, et al.
Rheumatology (Oxford, England)|January 31, 2020
Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritisUlf Sundin, Anna-Birgitte Aga, Øivind Skare, et al.
RMD Open|February 6, 2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategyUlf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al.
The Journal of Rheumatology|November 15, 2022
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARDImane Bardan, Karen M Fagerli, Joe Sexton, et al.
Annals of the Rheumatic Diseases|January 31, 2026
Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritisGina Hetland Brinkmann, Nina Paulshus Sundlisæter, Lena Bugge Nordberg, et al.
Annals of the Rheumatic Diseases|August 14, 2021
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatmentKaren Holten, Nina Paulshus Sundlisater, Siri Lillegraven, et al.
RMD Open|December 20, 2018
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trialLena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2018
The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control RegimenLena B Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
Annals of the Rheumatic Diseases|April 21, 2016
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteriaLena Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
RMD Open|January 12, 2024
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activityKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
Rheumatology (Oxford, England)|July 28, 2018
Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocolNina Paulshus Sundlisæter, Inge C Olsen, Anna-Birgitte Aga, et al.
Rheumatology (Oxford, England)|January 31, 2020
Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritisUlf Sundin, Anna-Birgitte Aga, Øivind Skare, et al.
RMD Open|February 6, 2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategyUlf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al.
The Journal of Rheumatology|November 15, 2022
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARDImane Bardan, Karen M Fagerli, Joe Sexton, et al.
Annals of the Rheumatic Diseases|January 31, 2026
Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritisGina Hetland Brinkmann, Nina Paulshus Sundlisæter, Lena Bugge Nordberg, et al.
Annals of the Rheumatic Diseases|August 14, 2021
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatmentKaren Holten, Nina Paulshus Sundlisater, Siri Lillegraven, et al.
RMD Open|December 20, 2018
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trialLena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2018
The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control RegimenLena B Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
Annals of the Rheumatic Diseases|April 21, 2016
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteriaLena Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, et al.
Pageof 4